call +44 (0) 20 7060 7474
or email us
Search Results for
"Cardiovascular Pharmaceutical Market Trends, to "
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
Title ![]() | Date ![]() | Price ![]() | Relevance ![]() |
|---|---|---|---|
| Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 Key market forecasts and growth opportunities Product Code: URC00021 | Aug 2007 | £895.00 | 100 % |
| Cardiovascular Disorders Market Outlook to 2012, The Product Code: RBI00201 | Feb 2008 | £1,995.00 | 36 % |
| Pediatric Drugs: the Worldwide Market 3rd Edition Product Code: KAL00107 | Dec 2007 | £1,990.00 | 36 % |
| World Market for Prescription Cardiovascular Drugs 2nd Edition Product Code: KAL00106 | Nov 2007 | £1,990.00 | 36 % |
| World Market for Prescription Generic Drugs 6th Edition Product Code: KAL00114 | Apr 2008 | £1,990.00 | 36 % |
| Drug Delivery Technology: Revolutionizing Cardiovascular Therapies Product Code: PAV00004 | Jul 2007 | £945.00 | 36 % |
| Pharmaceutical Markets in Brazil, Russia, India and China (Bric Nations) Product Code: KAL00126 | Jul 2008 | £1,745.00 | 36 % |
| Drug Treatments for Leading Endocrine and Metabolic Diseases Product Code: BCC00029 | Feb 2007 | £2,415.00 | 36 % |
| Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations ) Product Code: KAL00124 | Jul 2008 | £1,745.00 | 36 % |
| Obesity Drug Markets in the US and EU Analysis of product pipelines and the competitive environment Product Code: RBI00240 | Jul 2008 | £1,995.00 | 36 % |
| Pharmaceutical Market Trends, 2007-2011 Key market forecasts and growth opportunities (2nd Edition) Product Code: URC00017 | Nov 2007 | £995.00 | 36 % |
| The Specialty Pharma Market Outlook Key players, new company growth models and emerging opportunities Product Code: RBI00120 | Oct 2006 | £1,495.00 | 36 % |
| Pharmaceutical Product Approval Trends, 2007 Key Market Benchmarks And Strategic Insights Product Code: URC00024 | Dec 2007 | £1,299.00 | 36 % |
| Key Trends in Nutraceutical Food and Drinks Novel ingredients, new applications and future revenue opportunities Product Code: RBI00108 | Jan 2007 | £995.00 | 36 % |
| Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets Product Code: TRI00010 | Oct 2005 | £1,140.00 | 36 % |
| Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market Product Code: DAT11459 | Apr 2008 | £8,000.00 | 20 % |
| Martek Biosciences Corp: Premium Company Profile Product Code: DAT09536 | Jan 2008 | £265.00 | 20 % |
| Generic Drug Market in Canada Product Code: RCS00395 | Feb 2008 | £700.00 | 20 % |
| Global Trends in Reimbursement of Medical Technology Product Code: CLI00001 | Jan 2007 | £1,300.00 | 20 % |
| Emerging Pharmaceutical Markets Globally Product Code: RCS00409 | Apr 2008 | £750.00 | 20 % |
| Companion Animal Behavioral Products Product Code: ANP00006 | Jan 2007 | £895.00 | 20 % |
| Antiageing and Life Enhancement Pharmacotherapeutics Product Code: SPE00009 | Jan 2006 | £4,800.00 | 20 % |
| The Top 10 Generic Pharmaceutical Companies Positioning, Performance and SWOT Analyses Product Code: RBI00248 | Jul 2008 | £1,995.00 | 20 % |
| The Top 10 World's Leading Pharmaceutical Companies Product Code: VEP00130 | Jan 2008 | £6,580.00 | 20 % |
| Isis Pharmaceuticals Inc: Premium Company Profile Product Code: DAT09443 | Dec 2007 | £265.00 | 20 % |



previous



